Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL325261 | 0.88 | SOD1 (0.39) | ALDH1A1HPGDMAOADYRK1ASYK | |
| SCHEMBL3440051 | 0.86 | MEN1 (0.49) | MEN1KMT2ATP53ALOX15ALDH1A1 | |
| SCHEMBL19399855 | 0.86 | MEN1 (0.45) | MEN1KMT2ATP53ALOX15ALDH1A1 | |
| SCHEMBL17197212 | 0.82 | KDM4E (0.41) | MAOADYRK1AKDM4E | |
| SCHEMBL19121172 | 0.82 | ELANE (0.43) | KMT2ATP53ALOX15ALDH1A1MAPT | |
| SCHEMBL2212312 | 0.82 | TP53 (0.41) | TP53ALOX15ALDH1A1MAPTHPGD | |
| SCHEMBL8283580 | 0.81 | DRD2 (0.41) | TP53ALOX15ALDH1A1DRD2DRD4 | |
| SCHEMBL13021583 | 0.80 | MEN1 (0.45) | MEN1KMT2ATP53ALOX15ALDH1A1 | |
| SCHEMBL13413138 | 0.80 | KDM4E (0.42) | MEN1KMT2ATP53ALOX15ALDH1A1 | |
| SCHEMBL4604583 | 0.80 | ALDH1A1 (0.46) | MEN1KMT2ATP53ALOX15ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180212274-A1 | Process for Preparing Unipolar Cation-Conducting Ionomers from Difluoro Ionic Monomers | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2018-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180212274-A1 | Process for Preparing Unipolar Cation-Conducting Ionomers from Difluoro Ionic Monomers | INF2, ORAI1, ASIC1 | MEN1 345/4885KMT2A 2613/4885TP53 3198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.